Profound Medical (PROF) Income towards Parent Company (2023 - 2025)
Historic Income towards Parent Company for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$8.0 million.
- Profound Medical's Income towards Parent Company rose 1482.11% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 4408.95%. This contributed to the annual value of -$28.4 million for FY2024, which is 251.68% up from last year.
- Per Profound Medical's latest filing, its Income towards Parent Company stood at -$8.0 million for Q3 2025, which was up 1482.11% from -$15.7 million recorded in Q2 2025.
- In the past 5 years, Profound Medical's Income towards Parent Company ranged from a high of $7.3 million in Q2 2023 and a low of -$48.6 million during Q4 2023
- In the last 3 years, Profound Medical's Income towards Parent Company had a median value of -$6.9 million in 2024 and averaged -$8.4 million.
- The largest annual percentage gain for Profound Medical's Income towards Parent Company in the last 5 years was 8856.28% (2024), contrasted with its biggest fall of 26941.03% (2024).
- Profound Medical's Income towards Parent Company (Quarter) stood at -$48.6 million in 2023, then surged by 88.56% to -$5.6 million in 2024, then tumbled by 43.45% to -$8.0 million in 2025.
- Its Income towards Parent Company stands at -$8.0 million for Q3 2025, versus -$15.7 million for Q2 2025 and -$10.7 million for Q1 2025.